Summary

This document has been prepared by the Department of Health and Human Services to assist prescribers who have not undertaken the accredited one-day opioid pharmacotherapy prescriber training*, with general information on the key regulatory and policy requirements associated with the safe, appropriate and lawful prescribing of buprenorphine/naloxone.

Use this document with the Policy for Maintenance Pharmacotherapy for Opioid Dependence (2016).

Details

Publication Type
PDF
Topic
Policy and guidelines
Date Published
11 Jul 2017
Size
4 pages
Available format
PDF